Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ohr Pharma: A Pure 2014 Catalyst Play With Large Potential
Seeking Alpha
Tuesday, November 12, 2013 - 1:08pm
tags:
Ohr Pharmaceutical, wet-AMD, Squalamine Eye Drops, ovarian cancer
Endo Tax Edge for Deals Mimics Valeant Playbook: Real M&A
Bloomberg
Tuesday, November 12, 2013 - 11:04am
tags:
Endo Health Solutions, M&A, Valeant Pharmaceuticals
Will Galena Biopharma Triple Soon?
Wall St Cheat Sheet
Tuesday, November 12, 2013 - 10:06am
tags:
Galena Biopharma, Abstral
Home healthcare provider Amedisys reports quarterly loss
Reuters
Tuesday, November 12, 2013 - 9:56am
tags:
earnings, home healthcare, Amedisys
Boston Scientific's anti-stroke Watchman heart implant lands a date with the FDA
Mass Device
Tuesday, November 12, 2013 - 9:54am
tags:
Boston Scientific, stroke, WATCHMAN, devices
Glaxo’s Darapladib Fails to Prevent Heart Attacks in Test
Bloomberg
Tuesday, November 12, 2013 - 9:53am
tags:
GSK, darapladib, heart attacks
Sanofi Files 'First-Of-A-Kind' Lawsuit Against FDA Over OTC Drug
Pharmalot
Tuesday, November 12, 2013 - 9:50am
tags:
Sanofi, FDA, OTC, Nasacort
Gentium announces completion of defibrotide Phase 1 study in Japan
The Fly on the Wall
Tuesday, November 12, 2013 - 9:48am
tags:
Defibrotide, Japan, Gentium
Why You Should Be Watching Sarepta, Hologic, and Achillion Today
Motley Fool
Tuesday, November 12, 2013 - 9:41am
tags:
Achillion, Sarepta Therapeutics, Hologic, earnings, eteplirsen
A.P. Pharma Announces Pipeline Expansion
Yahoo
Tuesday, November 12, 2013 - 9:21am
tags:
AP Pharma, Sustol
Dendreon to restructure after drop in cancer drug sales
Yahoo/Reuters
Tuesday, November 12, 2013 - 9:17am
tags:
Dendreon, Provenge, restructuring
AVEO Q3 Loss Wider than Expected, Shares Down
Yahoo/Zacks.com
Tuesday, November 12, 2013 - 8:53am
tags:
earnings, Aveo Pharmaceuticals
FDA reviewer recommends approval of Vanda sleep drug for blind
The Fly on the Wall
Tuesday, November 12, 2013 - 8:52am
tags:
FDA, Vanda, non-24 hour disorder, tasimelteon
Why Northwest Biotherapeutics Rose 40% And Where From Here
Seeking Alpha
Tuesday, November 12, 2013 - 8:28am
tags:
Northwest Biotherapeutics, DCVax, brain cancer
Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen
TheStreet.com
Tuesday, November 12, 2013 - 7:59am
tags:
FDA, Sarepta Therapeutics, Duchenne Muscular Dystrophy, eteplirsen
Isis Pharmaceuticals earns $1.5M milestone payment from Biogen Idec
The Fly on the Wall
Tuesday, November 12, 2013 - 7:58am
tags:
Isis Pharmaceuticals, Biogen Idec, spinal muscular atrophy, ISIS-SMNRx
Ampio AWOL With Knee-Pain Drug Data Disclosures
TheStreet.com
Tuesday, November 12, 2013 - 7:26am
tags:
knee pain, Ampio Pharmaceuticals, Ampion
Glaxo Unit And Former CEO Win Lawsuit Over Alleged Fraud
Pharmalot
Monday, November 11, 2013 - 10:38pm
tags:
GSK, Charles Stiefel, Stiefel Labs, securities fraud
Novartis: Transfusion Tests Sale Does Not Point To Further Divestments
Seeking Alpha
Monday, November 11, 2013 - 10:36pm
tags:
Novartis, M&A, Grifols
FDA to charge generics makers with keeping safety labeling up to date
Fierce Pharma
Monday, November 11, 2013 - 2:36pm
tags:
FDA, generics, labeling

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.